Drug maker United Laboratories sells $125 million of CBs

United Laboratories International, a Hong Kong-listed Chinese manufacturer of generic Western drugs, yesterday raised Rmb790 million ($125 million) from the sale of convertible bonds. Being the first Asian CB since Rexlot Holdings’ $105 million Hong Kong dollar-denominated deal on September 21 and only the second trade since early August, the deal attracted a lot of attention as market participants look for a possible reopening of the CB market.